Vaccine Adjuvant
CD40 antibody is potent immunological adjuvant
Published in Vaccine Weekly, July 13th, 2005
"Agonistic antibodies against CD40 have great potential as immunological adjuvants. We have shown that CD40mAbs induce strong antibody responses against conjugated antigen, and that this enhancement of responses extends to any sequence physically associated to the CD40 binding moiety, including the antibody's own Fc region. Thus, the CD40mAb acts as a model immunogen, containing both antigenic (i.e., Fc portion) and CD40 binding motifs (i.e., CD40 binding moiety). Using this system we examine here whether CD40mAb is able to directly mimic T cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-07-13)
More Articles from Vaccine Weekly
- Alzheimer Disease
Humoral responses examined in monkeys vaccinated with A-beta vaccine - Cholera Vaccine
Vaccine candidate protects against cholera in healthy volunteers - Ebola Vaccine
Virus-like particles are candidates for Ebola and Marburg vaccines - Herpes Zoster Virus Vaccine
Vaccine prevents herpes zoster and neuralgia in older adults - Tularemia Vaccine
Intranasal vaccine protects against intranasal Francisella infection - Advocacy
Provider of HIV/AIDS medical care lauds U.S. Rep. Henry Waxman's stand on CAFTA - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
